These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34442400)

  • 1. Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy.
    Amabile MI; De Luca A; Tripodi D; D'Alberti E; Melcarne R; Imbimbo G; Picconi O; D'Andrea V; Vergine M; Sorrenti S; Molfino A
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study.
    Bacić I; Druzijanić N; Karlo R; Skifić I; Jagić S
    J Exp Clin Cancer Res; 2010 Feb; 29(1):12. PubMed ID: 20152024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
    Brandberg Y; Johansson H; Hellström M; Gnant M; Möbus V; Greil R; Foukakis T; Bergh J;
    Breast Cancer Res Treat; 2020 May; 181(1):87-96. PubMed ID: 32232698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
    Schwentner L; Harbeck N; Singer S; Eichler M; Rack B; Forstbauer H; Wischnik A; Scholz C; Huober J; Friedl TW; Weissenbacher T; Härtl K; Kiechle M; Janni W; Fink V
    Breast; 2016 Jun; 27():69-77. PubMed ID: 27054751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
    Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
    Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
    Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
    J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol hexaphosphate (InsP6) as an effective topical treatment for patients receiving adjuvant chemotherapy after breast surgery.
    Proietti S; Pasta V; Cucina A; Aragona C; Palombi E; Vucenik I; Bizzarri M
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):43-50. PubMed ID: 28724186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Properties of Inositol Hexaphosphate and Inositol: An Overview.
    Vucenik I
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S18-S22. PubMed ID: 31619624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol Hexaphosphate (IP6) and Colon Cancer: From Concepts and First Experiments to Clinical Application.
    Vucenik I; Druzijanic A; Druzijanic N
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33333775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
    Gadisa DA; Gebremariam ET; Ali GY
    Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial.
    Schneeweiss A; Möbus V; Tesch H; Hanusch C; Denkert C; Lübbe K; Huober J; Klare P; Kümmel S; Untch M; Kast K; Jackisch C; Thomalla J; Ingold-Heppner B; Blohmer JU; Rezai M; Frank M; Engels K; Rhiem K; Fasching PA; Nekljudova V; von Minckwitz G; Loibl S
    Eur J Cancer; 2019 Jan; 106():181-192. PubMed ID: 30528802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR-FTIR investigation on the complexation of myo-inositol hexaphosphate with aluminum hydroxide.
    Guan XH; Shang C; Zhu J; Chen GH
    J Colloid Interface Sci; 2006 Jan; 293(2):296-302. PubMed ID: 16111695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
    Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.
    Fu M; Song Y; Wen Z; Lu X; Cui L
    Nutrients; 2016 May; 8(5):. PubMed ID: 27187454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.
    Sarid D; Ron IG; Sperber F; Stadler Y; Kahan P; Kovner F; Ben-Yosef R; Marmor S; Grinberg Y; Maimon N; Weinstein J; Yaal-Hahoshen N
    Clin Drug Investig; 2006; 26(12):691-701. PubMed ID: 17274676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic.
    Vucenik I; Shamsuddin AM
    J Nutr; 2003 Nov; 133(11 Suppl 1):3778S-3784S. PubMed ID: 14608114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
    Cameron D; Morden JP; Canney P; Velikova G; Coleman R; Bartlett J; Agrawal R; Banerji J; Bertelli G; Bloomfield D; Brunt AM; Earl H; Ellis P; Gaunt C; Gillman A; Hearfield N; Laing R; Murray N; Couper N; Stein RC; Verrill M; Wardley A; Barrett-Lee P; Bliss JM;
    Lancet Oncol; 2017 Jul; 18(7):929-945. PubMed ID: 28600210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.